Skip to main content

HSBC HOLDINGS PLC

Position in PTGX — Protagonist Therapeutics, Inc

CIK 873630 LONDON, X0

Position in PTGX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,181,193
+$2,980,196 QoQ
Shares Held
25,952
+1260.9% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#121
of 341 holders
Holding Since
Jun 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PTGX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

HSBC HOLDINGS PLC holds $1,221,504,678 across 135 Biotechnology names. PTGX ranks #32 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PTGX

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,181,193 25,952
2026-03-31 $200,997 1,907
2025-06-30 $239,871 4,340
2025-03-31 $409,028 8,458
2024-12-31 $313,740 8,128
2024-09-30 $264,105 5,869
2024-06-30 $260,879 7,529
2024-03-31 $3,265,820 112,887
2023-12-31 $2,736,328 119,334
2023-09-30 $9,245,807 554,305
2023-06-30 $15,479,767 560,455